(untitled) - Schlumberger, MJ; Elisei, R; Sherman, SI
Phase 2 trial of motesanib diphosphate(AMG706) in patients with medullary thyroid cancer (MTC). Abstracts from the 89th Annual Meeting of the Endocrine Society, Toronto 2007.